By Igor Kossov ( November 5, 2014, 1:55 PM EST) -- Xenon Pharmaceuticals Inc. on Tuesday raised $36 million in its initial public offering, pricing below its intended range and missing its target by at least $4 million, showing that October's uncertainty about biotech offerings may still be present, despite capital markets starting to regain strength....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.